Press Releases

BOSTON, May 12, 2024 (GLOBE NEWSWIRE) -- The TrialWire™ Rapid Patient Recruitment Platform, the only pay-per-enrolled fixed-fee solution powered by AI and algorithms, has been selected as a finalist by Citeline in three key categories: 

• Best use of artificial intelligence in clinical trials
• Best patient-facing technology initiative
• Best sponsor-facing technology initiative

Try pay-per-enrollment starts in 24 hours

TrialWire™ not only finds highly eligible... (continue reading...)

MEXICO CITY--(BUSINESS WIRE)-- The International Federation of Air Line Pilots’ Associations officially closes another successful annual conference. IFALPA is pleased to announce the election results of the 78th Conference in Mexico City. Two Associations were voted into Membership by Conference and the Federation welcomes SNPL Morocco and ASOPLANE Ecuador.

In a landmark moment, IFALPA is proud to announce the election of the first two women to its Executive... (continue reading...)

DALLAS--(BUSINESS WIRE)-- This week, Brown Books Kids releases a timely children’s picture book. Mommy, Will You Rub My Feet? by debut author Jessica Jones with illustrations by Susana Ramírez Solís aims to help parents and children learn to identify growing pains. Jones’ cozy bedtime read is not only educational, but paired with Solís’ brilliantly muted color palette, it provides a comforting solace to soothe children to sleep.

Jones was inspired by a... (continue reading...)

NEW YORK, May 12, 2024 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of HireRight Holdings Corporation (NYSE: HRT) pursuant and/or traceable to the registration statement and prospectus (collectively, the “Offering Documents”) issued in connection with HireRight’s October 2021 initial public offering (the “IPO”), of the important June 3, 2024 lead plaintiff deadline.

SO WHAT: If you purchased... (continue reading...)

Company announcement – No. 25 / 2024

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

Copenhagen, Denmark, May 12, 2024 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a biotechnology company focused on the discovery and development of innovative peptide-based medicines, has received information on transactions in Zealand's shares or... (continue reading...)